6501 – 6510 of 7628
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2004
-
Mark
Quality assurance of patient dosimetry in boron neutron capture therapy
(
- Contribution to journal › Article
-
Mark
Neuroblastoma and pre-B lymphoma cells share expression of key transcription factors but display tissue restricted target gene expression
(
- Contribution to journal › Article
-
Mark
External quality assessment for mutation detection in the BRCA1 and BRCA2 genes: EMQN's experience of 3 years
(
- Contribution to journal › Article
-
Mark
Does stage at diagnosis explain the difference in survival after breast cancer in Denmark and Sweden?
(
- Contribution to journal › Article
-
Mark
Nordic studies on late effects of treatment of cancer in childhood and adolescence
(
- Contribution to journal › Letter
-
Mark
Generation of renal tubules at the interface of an artificial interstitium
(
- Contribution to journal › Article
-
Mark
The need for oncogenetic counselling - Ten years' experience of a regional oncogenetic clinic
(
- Contribution to journal › Article
-
Mark
A strategy for identifying putative causes of gene expression variation in human cancers
(
- Contribution to journal › Article
-
Mark
Re S. S. Virtanen et al., Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway. Cancer Res 2002;62 : 2708-14 - Re K. Sawada et al., Alendronate inhabits lysophosphatidic acid-induced migration of human ovarian cancer cells by attenuating the activation of Rho. Cancer Res 2002;62 : 6015-20 - Reply
(
- Contribution to journal › Letter
-
Mark
Expression profiling using tissue microarray in 211 malignant fibrous histiocytomas confirms the prognostic value of Ki-67.
(
- Contribution to journal › Article